20-31568163-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_178581.3(HM13):c.1120G>A(p.Asp374Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000719 in 1,613,030 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_178581.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HM13 | NM_178581.3 | c.1120G>A | p.Asp374Asn | missense_variant | 12/13 | ENST00000398174.9 | NP_848696.1 | |
HM13 | NM_178580.3 | c.1120G>A | p.Asp374Asn | missense_variant | 12/13 | NP_848695.1 | ||
HM13 | NM_030789.4 | c.1035-957G>A | intron_variant | NP_110416.1 | ||||
HM13-AS1 | NR_046853.2 | n.248-215C>T | intron_variant |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000237 AC: 36AN: 152162Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000101 AC: 25AN: 247742Hom.: 0 AF XY: 0.0000817 AC XY: 11AN XY: 134582
GnomAD4 exome AF: 0.0000548 AC: 80AN: 1460868Hom.: 0 Cov.: 31 AF XY: 0.0000592 AC XY: 43AN XY: 726724
GnomAD4 genome AF: 0.000237 AC: 36AN: 152162Hom.: 0 Cov.: 33 AF XY: 0.000256 AC XY: 19AN XY: 74318
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 01, 2024 | The c.1120G>A (p.D374N) alteration is located in exon 12 (coding exon 12) of the HM13 gene. This alteration results from a G to A substitution at nucleotide position 1120, causing the aspartic acid (D) at amino acid position 374 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at